ASTELLAS PHARMA UNSP.ADR Net Asset Momentum
ASTELLAS PHARMA UNSP.ADR net asset momentum. ASTELLAS PHARMA UNSP.ADR (YPHA) recorded a net asset momentum of -5.2% as of March 2025, with net assets of €1.51 Trillion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore how much does ASTELLAS PHARMA UNSP.ADR reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ASTELLAS PHARMA UNSP.ADR (2022–2025)
Net asset momentum of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. This chart tracks ASTELLAS PHARMA UNSP.ADR's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -5.2%, with net assets of €1.51 Trillion EUR as of March 2025. See shareholders equity of ASTELLAS PHARMA UNSP.ADR for net asset value and shareholders' equity analysis.
ASTELLAS PHARMA UNSP.ADR Net Asset Momentum by Year (2022–2025)
ASTELLAS PHARMA UNSP.ADR net asset momentum by year from 2022 to 2025. The table below shows the complete annual net asset history for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of ASTELLAS PHARMA UNSP.ADR.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €1.51 Trillion | €3.34 Trillion | €1.83 Trillion | ▼ -5.2% |
| 2024 | €1.60 Trillion | €3.57 Trillion | €1.97 Trillion | ▲ +5.8% |
| 2023 | €1.51 Trillion | €2.46 Trillion | €948.56 Billion | ▲ +3.3% |
| 2022 | €1.46 Trillion | €2.33 Trillion | €872.09 Billion | — |